Cancer-focused Genetic Testing Service Market Top Companies Study – Cleveland Clinic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cancer-focused Genetic Testing Service Market – (By Test Type (Chromosome Testing, DNA Testing, Direct DNA Testing, Indirect DNA Testing, Biochemical Genetic Testing), By Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Bladder Cancer, Kidney Cancer, Other), By Service Provider (Hospital, Specialty Clinics, Diagnostic Laboratories, Specialized Cancer Institutes)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Cancer-focused Genetic Testing Service Market is valued at US$ 7.82 Bn in 2023, and it is expected to reach US$ 14.41 Bn by 2031, with a CAGR of 8.2% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2622

The purpose of cancer-specific genetic testing is to analyze a person's genetic material in order to detect gene alterations that have the potential to enhance the chance of getting cancer. The provision of these services is essential in order to facilitate the development of individualized treatment strategies, early diagnosis, and prevention actions for genetic profiles. The next-generation sequencing (NGS) technique is widely used to conduct a thorough and speedy study of a large number of genes. It is projected that there will be a rise in the demand for genetic testing that is intended to particularly target cancer on a worldwide scale. This development may be attributed to a number of factors, comprising the rising prevalence of cancer, the growing awareness of the need for early detection, and the breakthroughs that have been made in genetic testing. With the use of genetic testing and precision medicine in clinical settings, the sector is seeing significant growth.